Recent evidence has demonstrated that nicotine may obtund the symptoms
of Tourette's syndrome (TS). TS is a neuropsychiatric disorder charac
terized by motor and vocal ties, obsessions and compulsions, and frequ
ently with impulsivity, distractibility, and visual-motor deficits. Wh
ile neuroleptics, such as haloperidol, are most effective for treatmen
t of the motor and vocal ties of TS, these medications have many side
effects. In this article, we review the evidence, consistent with find
ings in animals, that administration of nicotine (either 2 mg nicotine
gum or 7 mg transdermal nicotine patch) potentiates the therapeutic p
roperties of neuroleptics in treating TS patients and that a single pa
tch may be effective for a variable number of days. These findings sug
gest that transdermal nicotine could serve as an effective adjunct to
neuroleptic therapy for TS. (C) 1997 Elsevier Science Inc.